Torthaí cuardaigh - Sharon Webster
- 1 - 3 toradh as 3 á dtaispeáint
-
1
Interim analysis: Open-label extension study of leniolisib for patients with APDS de réir V. Koneti Rao, Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A. S. H. Dalm, Antonino Trizzino, Yulia Zharankova, Sharon Webster, Alanvin Orpia, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Kath Radford, Jason Bradt, Anurag Relan, Steven M. Holland, Michael J. Lenardo, Gulbu Uzel
Foilsithe / Cruthaithe 2023Artigo -
2
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome de réir V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil A. S. H. Dalm, Antonino Trizzino, Yulia Zharankova, Elaine Kulm, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Kath Radford, Jason Bradt, Klaus Kucher, Anurag Relan, Steven M. Holland, Michael J. Lenardo, Gülbû Uzel
Foilsithe / Cruthaithe 2022Artigo -
3
Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib de réir V. Koneti Rao, Sharon Webster, Virgil A. S. H. Dalm, Anna Šedivá, P. Martin van Hagen, Steven M. Holland, Sergio D. Rosenzweig, Andreas D. Christ, Birgitte Sloth, Maciej Cabanski, Aniket Joshi, Stefan Buck, Julie Doucet, Danilo Guerini, Christoph Kalis, Ilona Pylvaenaeinen, Nicolas Soldermann, Anuj Kashyap, Gülbû Uzel, Michael J. Lenardo, Dhavalkumar D. Patel, C. Lucas, Christoph Burkhart
Foilsithe / Cruthaithe 2017Artigo